Followers | 132 |
Posts | 14996 |
Boards Moderated | 0 |
Alias Born | 06/04/2018 |

Wednesday, November 04, 2020 12:00:26 PM
Next generation anti- Aβ antibod ies being developed for subcutaneous administration to improve access for patient s with Alzheimer’s disease Multi- i mmunogen Aβ- t au va ccine ...
Find out more PRTA - Prothena Announces Presentations on Two Programs from its Alzheimer's Disease Portfolio at CTAD 2020
@whytestocks
Recent PRTA News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 06/04/2025 09:18:42 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/30/2025 01:08:14 AM
- Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint • Business Wire • 05/23/2025 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2025 08:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 08:10:38 PM
- Prothena Reports First Quarter 2025 Financial Results and Business Highlights • Business Wire • 05/08/2025 08:05:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/06/2025 11:08:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2025 11:06:05 PM
- Prothena to Report First Quarter 2025 Financial Results on May 8 • Business Wire • 05/01/2025 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/28/2025 08:37:47 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/28/2025 08:35:24 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/28/2025 08:06:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 09:51:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 09:45:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 09:41:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 09:30:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 09:28:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 09:24:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2025 10:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2025 09:07:28 PM
- Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights • Business Wire • 02/20/2025 09:05:00 PM
- Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 • Business Wire • 02/13/2025 09:05:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/04/2025 12:45:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2024 09:07:58 PM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM
NEXT10, Inc. Announces Acquisition of Torreon Group, Inc. • NXTN • Jun 9, 2025 8:42 AM
Maybacks Global Entertainment, LLC and Plex Sign Global Licensing and Distribution Agreement • AHRO • Jun 6, 2025 8:30 AM
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership • BLOZF • Jun 5, 2025 8:54 AM